Diffuse malignant mesothelioma. Prospective evaluation of 69 patients

Annals of Internal Medicine

Volumn 96, Issue 6 I, 1982, Pages 746-755

  Chahinian, A P ^a   Pajak, T F ^a   Holland, J F ^a   Norton, L ^b   Ambinder, R M ^b   Mandel, E M ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; AZACITIDINE; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; MICA; SEMUSTINE; TALC;

ADVERSE DRUG REACTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CARDIOVASCULAR SYSTEM; FAMILIAL MEDITERRANEAN FEVER; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALIGNANT MESOTHELIOMA; PERITONEUM; PERITONEUM CANCER; PLEURA; PLEURA CANCER; RADIOTHERAPY; RESPIRATORY SYSTEM; THERAPY; THROMBOCYTOSIS; THROMBOEMBOLISM;

EID: 0019977891     PISSN: 00034819     EISSN: None     Source Type: None    
DOI: 10.7326/0003-4819-96-6-746     Document Type: Article

References (0)